Company news

Fleury Sa (BMFBOVESPA:FLRY3) news

Fleury Sa news releases on 6ix. Latest, May 8, 2026: Fleury: Q1 2026 delivered double-digit revenue and net income growth, led by B2C and premium segments

View Fleury Sa →

Press releases & updates

Fleury: Q1 2026 delivered double-digit revenue and net income growth, led by B2C and premium segments

May 8, 2026

Fleury: Gross revenue up 10.1% to R$2.4B, EBITDA up 10.7%, net income up 12.2%, ROIC at 17.0%

May 7, 2026

Oncoclinicas ends talks with Porto and Fleury, weighs new deals

April 14, 2026

Brazil's Fleury, Porto end talks to create new firm with Oncoclinicas, reports O Globo

April 13, 2026

Brazil's Fleury enters talks on new company with Oncoclinicas, Porto

March 23, 2026

Fleury: Q4 2025 saw double-digit revenue and profit growth, with strong B2C and New Links momentum

March 6, 2026

Fleury: Double-digit revenue and EBITDA growth in 4Q25, driven by B2C and strategic acquisitions

March 5, 2026

Brazil's Fleury Approves Buyback Program Of Up To 2.3 Mln Shares

February 3, 2026

Fleury: Revenue up 11.5% to R$2.4b, EBITDA margin steady, and leverage at 1.0x

November 7, 2025

Fleury Q3 Net Profit 185 Mln Reais Vs IBES Estimate 180 Mln Reais

November 6, 2025

Brazilian Lab Chain Fleury Buys Gip Medicina Diagnostica For 207.5 Mln Reais

November 4, 2025

Brazil's Fleury signs contract to buy laboratory LSL for 34 million reais

October 28, 2025

Brazil's Fleury falls on reports of Rede D'Or discussions halt

October 20, 2025

Fleury: B2C growth offset B2B declines, with stable margins but lower net income year-over-year

August 8, 2025

Fleury Q2 net profit 152 million reais vs IBES estimate 166 million reais

August 7, 2025

Brazil's Fleury signs purchase of Hemolab for 39.5 million reais

June 11, 2025

Fleury: Revenue up 6.5% and ROIC at 16.9%, with digital and regional growth offsetting B2B decline

May 9, 2025

Brazil's Fleury posts Q1 net profit of 179 mln reais

May 8, 2025

Fleury: Strong growth, expanded reach, and robust ESG drive leadership in Brazilian diagnostic medicine

March 13, 2025

Fleury: Grupo Fleury posted double-digit revenue and net income growth in 2024, with enhanced margins and cash flow

February 28, 2025

Fleury: Revenue, EBITDA, and net income all grew, with strong B2B and mobile service performance

November 8, 2024

Fleury: 2Q24 saw double-digit revenue and profit growth, with integration synergies boosting performance

August 9, 2024